BridgeBio Pharma Inc, located in Palo Alto, CA, is a pioneering biopharmaceutical company that focuses on designing transformative medicines for patients suffering from genetic diseases and cancers driven by clear genetic factors. With a mission to bring finance and science together, BridgeBio Pharma takes a wholly new approach to drug development, aiming to provide hope to patients through rigorous scientific research.
Driven by their discovery and development engine, BridgeBio Pharma swiftly converts scientific breakthroughs into patient solutions, striving to deliver transformative medicines as quickly as humanly possible. With an extensive pipeline of innovative therapies, BridgeBio Pharma is dedicated to improving the lives of patients and their families by addressing the underlying genetic drivers of their conditions.
Generated from the website
